← Back to Search

ropivicaine 0.2% for Pain Management

Phase 4
Waitlist Available
Led By Anthony Morlandt, MD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 days
Awards & highlights

Study Summary

This trial will test whether regional anesthesia is safe and effective for head and neck patients undergoing a specific type of surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 21 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Opioid Utilization Measured in Oral Morphine Equivalent (OME)
Secondary outcome measures
Opioid Medication Use

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Experimental GroupExperimental Treatment1 Intervention
US-guided ipsilateral sciatic nerve block for fibula free flap patients utilizing ropivacaine 0.2% at 2-8 cc/hr for fibula free flap patients; US-guided infraclavicular brachial plexus nerve block for forearm free lap patients utilizing ropivacaine 0.2% at 2-8cc/hr for forearm free flap patients.
Group II: Control GroupActive Control1 Intervention
No regional anesthetic of any kind during the surgical procedure.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ropivicaine 0.2%
2020
Completed Phase 4
~100

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,583 Previous Clinical Trials
2,279,944 Total Patients Enrolled
3 Trials studying Pain Management
468 Patients Enrolled for Pain Management
Anthony Morlandt, MD4.611 ReviewsPrincipal Investigator - University of Alabama at Birmingham
University of Alabama at Birmingham
5Patient Review
I'm glad my previous doctor recommended Dr. Smith.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are eligible to join this clinical investigation?

"Affirmative. According to the data stored on clinicaltrials.gov, this medical trial is actively seeking participants; it was initially released on January 13th 2020 and has been revised most recently on May 10th 2022. The study needs 50 patients from a single facility for successful completion."

Answered by AI

Is it feasible to enrol in this research project?

"According to the information provided on clinicaltrials.gov, this medical trial is presently recruiting research participants and has been since January 13th 2020; its most recent update was recorded on May 10th 2022."

Answered by AI

In what medical procedures is ropivicaine 0.2% typically employed?

"Ropivicaine 0.2% is a recommended anesthetic for procedures needing anesthesia, surgery related anesthesia, and pain relief during childbirth."

Answered by AI

Has the FDA given its approval for ropivicaine 0.2%?

"Our internal evaluation of the safety profile for ropivicaine 0.2% is a 3, since this Phase 4 trial has already been approved by regulatory bodies."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Regional Block for Postoperative Free Flap Care
Anthony Morlandt 2020. "Regional Block for Postoperative Free Flap Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04080739.
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top